← Evidence map

ArticleThe journal of liquid biopsy2026

Early tumor-informed circulating tumor DNA (ctDNA) dynamics correlate with response to first-line advanced NSCLC treated with pembrolizumab ± chemotherapy.

Diego Enrico et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Early tumor-informed circulating tumor DNA (ctDNA) dynamics correlate with response to first-line advanced NSCLC treated with pembrolizumab ± chemotherapy. | OpenQuestion